neuroleptic malignant syndrome nms lifethreatening reaction occur response antipsychotic neuroleptic symptoms include high fever confusion rigid muscles variable blood pressure sweating fast heart complications may include rhabdomyolysis high blood potassium kidney failure medications within family antipsychotics cause condition though typical antipsychotics appear higher risk specifically first generation antipsychotics like onset often within weeks starting medication occur risk factors include dehydration agitation rapidly decreasing use levodopa dopamine agonists pramipexole may also trigger underlying mechanism involves blockage dopamine diagnosis based management includes stopping triggering medication rapid cooling starting medications used include dantrolene bromocriptine risk death among affected rapid diagnosis treatment required improve many people eventually restarted lower dose among psychiatric hospitals antipsychotics per affected per year second half century rates times higher per males appear often affected condition first described nms symptoms first symptoms neuroleptic malignant syndrome usually muscle cramps tremors fever symptoms autonomic nervous system instability unstable blood pressure sudden changes mental status agitation delirium coma symptoms appear may progress rapidly reach peak intensity little three symptoms last anywhere eight hours forty symptoms sometimes misinterpreted doctors symptoms mental illness result delayed nms less likely person previously stable period time antipsychotics especially situations dose changed issues noncompliance consumption psychoactive substances known worsen psychosiscitation needed nms usually caused antipsychotic drug use wide range drugs result individuals using butyrophenones haloperidol droperidol phenothiazines promethazine chlorpromazine reported greatest risk however various atypical antipsychotics clozapine olanzapine risperidone quetiapine ziprasidone also implicated nms may also occur people taking dopaminergic drugs levodopa parkinsons disease often drug dosage abruptly addition drugs antidopaminergic activity antiemetic metoclopramide induce tetracyclics antidopaminergic activity linked nms case reports amoxapines additionally desipramine dothiepin phenelzine tetrabenazine reserpine known trigger whether lithium cause nms however concomitant use lithium associated higher risk nms patient starts antipsychotic molecular level nms caused sudden marked reduction dopamine activity either withdrawal dopaminergic agents blockade dopamine one clearest risk factors development nms course drug therapy chosen treat condition use highpotency antipsychotics rapid increase dosage antipsychotics use longacting forms antipsychotics haloperidol known increase risk developing appears relationship duration therapy development use following agents commonly associated development purported genetic risk factor one study identical twins presented nms mother two daughters presented nms another demographically appears males especially forty greatest risk developing nms although unclear increased incidence result greater antipsychotic use men also suggested postpartum women may greater risk important risk factor condition lewy body dementia patients extremely sensitive antipsychotics result antipsychotics used cautiously cases mechanism commonly thought depend decreased levels dopamine activity due proposed blockade receptors induce massive glutamate release generating catatonia neurotoxicity additionally blockade diverse serotonin receptors atypical antipsychotics activation receptors certain reduces gaba release indirectly induces glutamate release worsening muscular symptoms likely caused blockade dopamine receptor leading abnormal function basal ganglia similar seen parkinsons past research clinical studies seemed corroborate receptor blockade theory antipsychotic drugs thought significantly reduce dopamine activity blocking receptors associated neurotransmitter introduction atypical antipsychotic drugs lower affinity dopamine receptors thought reduced incidence nms however recent studies suggest decrease mortality may result increased physician awareness earlier initiation treatment rather action drugs nms induced atypical drugs also resembles classical nms induced typical antipsychotic drugs casting doubt overall superiority however failure dopamine receptor antagonism dopamine receptor dysfunction fully explain presenting symptoms signs nms well occurrence nms atypical antipsychotic drugs lower dopamine led hypothesis sympathoadrenal hyperactivity results removing tonic inhibition sympathetic nervous system mechanism release calcium increased sarcoplasmic reticulum antipsychotic usage result increased muscle contractility play role breakdown muscle muscle rigidity hyperthermia antipsychotic drugs typical antipsychotics known block dopamine receptors studies shown drugs supplying dopamine withdrawn symptoms similar nms present support sympathoadrenal hyperactivity model hypothesized defect calcium regulatory proteins within sympathetic neurons may bring onset model nms strengthens suspected association malignant hyperthermia nms may regarded neurogenic form condition linked defective calciumrelated proteinscitation needed also thought considerable overlap malignant catatonia nms pathophysiology former idiopathic latter druginduced form raised white blood cell count creatine phosphokinase cpk plasma concentration seen nms due increased muscular activity rhabdomyolysis destruction muscle patient may experience hypertensive crisis metabolic acidosis nongeneralized slowing eeg reported around casescitation needed fever seen nms believed caused hypothalamic dopamine receptor blockade peripheral problems high white blood cell cpk count caused antipsychotic drugs cause increased calcium release sarcoplasmic reticulum muscle cells result rigidity eventual cell breakdown major studies reported explanation abnormal eeg likely also attributable dopamine blockage leading changes neuronal due comparative rarity nms often overlooked immediate treatment syndrome delayed high mortality differentiating nms neurological disorders difficult requires expert judgement separate symptoms nms diseases diagnosis suggested patients accurate history drug exposure common inducing agents strong antidopaminergic differential diagnosis includes serotonin encephalitis toxic encephalopathy status epilepticus heat stroke catatonia malignant hyperthermia drugs cocaine amphetamine may also produce similar features distinguish nms serotonin syndrome include bradykinesia muscle rigidity high white blood cell nms medical emergency lead death untreated first step stop antipsychotic medication treat hyperthermia aggressively cooling blankets ice packs axillae groin supportive care intensive care unit capable circulatory ventilatory support crucial best pharmacological treatment still unclear dantrolene used needed reduce muscle rigidity recently dopamine pathway medications bromocriptine shown amantadine another treatment option due dopaminergic anticholinergic effects apomorphine may used however use supported little benzodiazepines may used control agitation highly elevated blood myoglobin levels result kidney damage therefore aggressive intravenous hydration diuresis may required recognized early nms successfully managed however cases affected person subsequently require antipsychotic trialing low dose lowpotency atypical antipsychotic prognosis best identified early treated aggressively cases nms usually fatal earlier studies mortality rates nms ranged mortality rates reported fallen previous two decades due early recognition improved reintroduction drug originally caused nms develop may also trigger recurrence although cases notcitation needed memory impairment consistent feature recovery nms usually temporary though cases may become pooled data suggest incidence nms however greater physician awareness coupled increased use atypical antipsychotics likely reduced prevalence additionally young males particularly susceptible malefemale ratio reported high nms known early shortly introduction first source nms first described french clinicians working study involving haloperidol characterized condition associated side effects haloperidol syndrome malin des neuroleptiques translated neuroleptic malignant disease httpsenwikipediaorgwikineurolepticmalignantsyndrome